Overall, when compared among all examined cutaneous malignancies, Dicer up-regulation was tumor-type specific by immunostaining, as Dicer was highly expressed by melanomas (metastatic and cutaneous) compared to carcinomas or sarcomas (P<0.0001, Fig. 3A). Here, DICER1 is linked to carcinoma.